Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
Clinical trial NCT06832267 · RECRUITING
Trial details
- NCT number
- NCT06832267
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-14
- Primary completion
- 2027-02-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.